3DPrint.com May 15, 2024
Vanesa Listek

Building on its proven track record in groundbreaking projects like glaucoma stents and microneedles, Boston Micro Fabrication (BMF) launched a new subsidiary, BMF Biotechnology Inc. Headquartered in San Diego, California, the division uses the brand’s 3D printing technology to create and commercialize microfluidic chips that accurately mimic human body functions. These organ-on-a-chip platforms or BioChips will allow faster, more precise testing and research for pharmaceutical and cosmetic industries, opening up new possibilities for medical progress and better patient care.

What Are BioChips?

Equipped with an integrated network of tiny channels that function similarly to blood vessels in the human body, these chips allow the flow of fluids, mimicking how nutrients and wastes are exchanged in human tissues. This is key...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: 3D Printing, Technology
Top 10 Moonshot Ideas for 3D Printing’s Future
3D Printing Predictions for 2026: Scaling AM Through Software
How 3D Printing is Making the World a Better Place, One Medical Innovation at a Time
Will Growth in Robotics Spawn More 3D Printing?
Who Merged, Who Was Acquired, and Who Disappeared in 3D Printing in 2025

Share Article